Literature DB >> 15491288

Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells.

T Otsuki1, K Yata, A Takata-Tomokuni, F Hyodoh, Y Miura, H Sakaguchi, T Hatayama, S Hatada, T Tsujioka, Y Sato, H Murakami, Y Sadahira, T Sugihara.   

Abstract

The neuron cytoplasmic protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) protein is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal of ubiquitin, and is involved in the processing of ubiquitin precursors and ubiquinated proteins. Although this molecule is known as a specific tissue marker for the neuroendocrine system, many reports have indicated that PGP9.5 is a marker for certain tumour types, such as cancer of the lung, colon, and pancreas. The expression of PGP9.5 in myeloma cells was examined. PGP9.5 seemed to be expressed specifically in myeloma cells as compared with other haematological malignant cells. In addition, in myeloma cells subjected to growth-factor starvation, the upregulation of PGP9.5 was observed in association with that of p27(Kip1), a cyclin-dependent-kinase inhibitor, although the upregulation caused by irradiation was milder. In contrast, the hypoxic culture of myeloma cells induced down-regulation of PGP9.5. These results suggested that PGP9.5 may be a good marker for myeloma among haematological malignancies. In addition, it may indicate certain cellular features of myeloma cells, such as sensitivity to proteasome inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15491288     DOI: 10.1111/j.1365-2141.2004.05205.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  25 in total

1.  Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.

Authors:  Christine Schröder; Karin Milde-Langosch; Florian Gebauer; Katharina Schmid; Volkmar Mueller; Ralph M Wirtz; Catherine Meyer-Schwesinger; Hartmut Schlüter; Guido Sauter; Udo Schumacher
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-31       Impact factor: 4.553

2.  UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.

Authors:  Yanhong Luo; Jianfeng He; Chunlin Yang; Matthew Orange; Xingcong Ren; Nick Blair; Tao Tan; Jin-Ming Yang; Hua Zhu
Journal:  J Cell Biochem       Date:  2017-07-31       Impact factor: 4.429

3.  Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor.

Authors:  Aaron D Krabill; Hao Chen; Sajjad Hussain; Chao Feng; Ammara Abdullah; Chittaranjan Das; Uma K Aryal; Carol Beth Post; Michael K Wendt; Paul J Galardy; Daniel P Flaherty
Journal:  Chembiochem       Date:  2019-11-07       Impact factor: 3.164

4.  The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.

Authors:  S Hussain; O Foreman; S L Perkins; T E Witzig; R R Miles; J van Deursen; P J Galardy
Journal:  Leukemia       Date:  2010-06-24       Impact factor: 11.528

Review 5.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

6.  Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors.

Authors:  Huang-Chun Lien; Chung-Chieh Wang; Chiun-Sheng Huang; Ya-Wen Yang; Wen-Hung Kuo; Yu-Tung Yao
Journal:  Virchows Arch       Date:  2013-01-05       Impact factor: 4.064

Review 7.  Neuroendocrine differentiation and the ubiquitin-proteasome system in cancer: Partners or enemies?

Authors:  Panagiotis J Vlachostergios; Christos N Papandreou
Journal:  World J Exp Med       Date:  2011-12-20

8.  Multifarious proteomic signatures and regional heterogeneity in glioblastomas.

Authors:  Chul-Kee Park; Ji Hye Jung; Sung-Hye Park; Hee-Won Jung; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2009-02-15       Impact factor: 4.130

9.  Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.

Authors:  Madeleine Zetterberg; Annica Sjölander; Malin von Otter; Mona Seibt Palmér; Sara Landgren; Lennart Minthon; Anders Wallin; Niels Andreasen; Kaj Blennow; Henrik Zetterberg
Journal:  Mol Neurodegener       Date:  2010-03-19       Impact factor: 14.195

10.  Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.

Authors:  Barbara Seliger; Diana Handke; Elisabeth Schabel; Juergen Bukur; Rudolf Lichtenfels; Reinhard Dammann
Journal:  J Transl Med       Date:  2009-10-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.